• Profile
Close

Higher serum 25-hydroxyvitamin D concentrations are associated with active pulmonary tuberculosis in hospitalised HIV infected patients in a low income tropical setting: A cross sectional study

BMC Pulmonary Medicine May 13, 2018

Musarurwa C, et al. - Researchers determined the prevalence, covariates of vitamin D deficiency (VDD) and risk of pulmonary tuberculosis (PTB) among human immunodeficiency virus (HIV)- infected hospitalized patients with and without PTB. Among hospitalised HIV-infected patients in the present study, a link was observed between higher serum 25-hydroxyvitamin D [25(OH) D] concentrations and active PTB and tuberculosis (TB)-related mortality. This finding is at variance with the commonly reported relation of hypovitaminosis and susceptibility to TB.

Methods

  • This comparative cross-sectional study included 145 HIV+/pulmonary TB+ (PTB) and 139 HIV+/PTB- hospitalised patients.
  • From participants enrolled in a randomised controlled trial (RCT) conducted to investigate the impact of using a point-of-care urine lipoarabinomannan strip test for TB diagnosis, archived serum specimens were selected using stratified random sampling.
  • Sputum smear microscopy, culture or GeneXpert MTB/RIF were used to corroborate PTB status.
  • Prior to commencement of anti-TB treatment, competitive chemiluminescent immunoassay was used to assay serum 25-hydroxyvitamin D [25(OH) D] concentrations.
  • Researchers determined the impact of VD status on duration of hospital stay and patient outcomes on follow up at 8 weeks.
  • Using Mann-Whitney test, median serum 25(OH) D concentrations were compared.
  • They assessed covariates of serum VD status using logistic regression analysis.

Results

  • The reported overall VDD prevalence in the cohort was 40.9% (95% CI: 35.1–46.8).
  • Significantly higher median serum 25(OH)D concentrations were detected in HIV+/PTB+ group (25.3 ng/ml, IQR:18.0–33.7) vs the HIV+/PTB- group (20.4 ng/ml, IQR:14.6–26.9), p=0.0003.
  • Relative to those with serum 25(OH) D concentrations + (odds ratio (OR) 1.91; 95% CI 1.1–3.2).
  • PTB-related death was found to be related to higher odds of having 25(OH) D levels≥30 ng/ml.
  • No association of age, gender, CD4+ count, combination antiretroviral therapy (cART) status, efavirenz based cART regimen and length of hospital stay with vitamin D status was found.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay